2015
DOI: 10.1016/j.jddst.2015.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology

Abstract: The objective of this study was to enhance the solubility as well as to mask the intensely bitter taste of the poorly soluble drug, Mefenamic acid (MA). The taste masking and solubility of the drug was improved by using Eudragit® E PO in different ratios via hot melt extrusion (HME), solid dispersion technology. Differential scanning calorimetry (DSC) studies demonstrated that MA and E PO were completely miscible up to 40% drug loads. Powder X-ray diffraction analysis indicated that MA was converted to its amo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
29
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 49 publications
(31 citation statements)
references
References 35 publications
(33 reference statements)
2
29
0
Order By: Relevance
“…For example, extrudates were produced by HME using water soluble cationic model drugs and various grades of anionic polymers (Eudragit L100 and Eudragit L100-55 (Acryl EZE)). It was found that the products not only had a significant taste masking effect, but also showed fast release for most drug substances (74)(75)(76).…”
Section: Formation Of Embedded Structures With Hot-melting Extrusion mentioning
confidence: 99%
“…For example, extrudates were produced by HME using water soluble cationic model drugs and various grades of anionic polymers (Eudragit L100 and Eudragit L100-55 (Acryl EZE)). It was found that the products not only had a significant taste masking effect, but also showed fast release for most drug substances (74)(75)(76).…”
Section: Formation Of Embedded Structures With Hot-melting Extrusion mentioning
confidence: 99%
“…The extrudates increased the API's solubility in media with acidic pH, when it was present in concentra-tion up to 25% in the mixture, due to the amorphous state of the drug. Extrudates containing 20% and 25% were milled and compressed into orodispersible tablets, which provided fast disintegration times, potential taste masking, improved API solubility and overall stability (Alshehri et al, 2015). Gryczke et al (2011) developed orodispersible tablets based on solid solutions of ibuprofen in pH sensitive metacrylic polymer (Eudragit® EPO).…”
Section: Taste Masking and Patient Friendly Dosage Formsmentioning
confidence: 99%
“…Several researchers have suggested that owing to lower porosity and higher tortuosity, diffusion-controlled sustained-release dosage forms prepared using the HME technique have slower drug release rates than those prepared by traditional methods [12, 13]. Additionally, HME has been widely used to enhance the dissolution rate of actives via preparation of solid dispersions for immediate and sustained-release applications [11, 14, 15]. …”
Section: Introductionmentioning
confidence: 99%